Stockreport

Veracyte outlines 10%–13% revenue growth for 2026 while advancing MRD and Prosigna launches [Seeking Alpha]

Veracyte, Inc.  (VCYT) 
Last veracyte, inc. earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.veracyte.com/investor-relations
PDF Marc Stapley, CEO, reported "Q4 capped off another outstanding year of strong execution for Veracyte with performance across our core businesses that reinforces both th [Read more]